Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    03-30-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-009600.pdf
    0001493152-23-009600.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    03-30-2023 10-K

    Annual report which provides a comprehensive overview of the company for the past year

    View HTML
    0001401914-23-000013.pdf
    0001401914-23-000013.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    03-13-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-007352.pdf
    0001493152-23-007352.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    02-06-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-003634.pdf
    0001493152-23-003634.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    01-27-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-002809.pdf
    0001493152-23-002809.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    01-26-2023 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-23-000006.pdf
    0001401914-23-000006.xls
    01-26-2023 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-23-000007.pdf
    0001401914-23-000007.xls
    01-26-2023 4

    Statement of changes in beneficial ownership of securities

    View HTML
    0001401914-23-000008.pdf
    0001401914-23-000008.xls
    01-25-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-002389.pdf
    0001493152-23-002389.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
    01-09-2023 8-K

    Report of unscheduled material events or corporate event

    View HTML
    0001493152-23-000904.pdf
    0001493152-23-000904.xls
    EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

    Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • …
    • Next page Next ›
    • Last page Last »

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2023 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top